CoChat

Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity

Open access
Harati, Rania, Villégier, Anne-Sophie, Banks, William A, Mabondzo, Aloise · 2012 · Journal of Neuroinflammation

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Background: P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) play a critical role in keeping neurotoxic substances from entering the brain. We and others have previously reported an impact of inflammation on the regulation of adult blood–brain barrier (BBB) efflux transporters. However, studies in children have not been done. From the pediatric clinical perspective, it is important to understand how the central nervous system (CNS) and BBB drug efflux transporters differ in childhood from those of adults under normal and inflammatory conditions. Therefore, we examined and compared the regulation of P-gp and BCRP expression and transport activity in young and adult BBB and investigated the molecular mechanisms underlying inflammatory responses. Methods: Rats at postnatal day (P) P21 and P84, corresponding to the juvenile and adult stages of human brain maturation, respectively, were treated with endothelin-1 (ET-1) given by the intracerebroventricular (icv) route. Twenty-four hours later, we measured P-gp and BCRP protein expression in isolated brain capillary by immunoblotting as well as by transport activity in vivo by measuring the unbound drug partitioning coefficient of the brain (K p,uu,brain) of known efflux transporter substrates administered intravenously. Glial activation was measured by immunohistochemistry. The release of cytokines/chemokines (interleukins-1α, 1-β (IL-1β), -6 (IL-6), -10 (IL-10), monocyte chemoattractant protein (MCP-1/CCL2), fractalkine and tissue inhibitor of metalloproteinases-1 (TIMP-1)) were simultaneously measured in brain and serum samples using the Agilent Technology cytokine microarray. Results: We found that juvenile and adult BBBs exhibited similar P-gp and BCRP transport activities in the normal physiological conditions. However, long-term exposure of the juvenile brain to low-dose of ET-1 did not change BBB P-gp transport activity but tended to decrease BCRP transport activity in the juvenile brain, while a significant increase of the activity of both transporters was evidenced at the BBB in the adult brain. Moreover, juvenile and adult brain showed differences in their expression profiles of cytokines and chemokines mediated by ET-1. Conclusions: BBB transporter activity during neuroinflammation differs between the juvenile and adult brains. These findings emphasize the importance of considering differential P-gp and BCRP transport regulation mechanisms between adult and juvenile BBB in the context of neuroinflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-9-273

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Scheme 1 An illustration of the experimental design. 1. Verification of intracerebroventricular (icv) stereotaxic coordinates. 2. Blood–brain barrier (BBB) integrity assessment. 3. P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) expression measurement. 4. P-gp and BCRP transport activity measurement. 5. Glial activation evaluation by glial fibrillary acid protein (GFAP) immunohistochemistry. 6. Brain and serum cytokines/chemokines quantification.
Scheme 1 An illustration of the experimental design. 1. Verification of intracerebroventricular (icv) stereotaxic coordinates. 2. Blood–brain barrier (BBB) integrity assessment. 3. P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) expression measurement. 4. P-gp and BCRP transport activity measurement. 5. Glial activation evaluation by glial fibrillary acid protein (GFAP) immunohistochemistry. 6. Brain and serum cytokines/chemokines quantification.CC BY · PubMed Central
Figure 1 Representative immunohistochemical staining of albumin in the adult and juvenile brains (scale bars, 5 μm).A) Stereotaxic implantation of the cannulae was checked using intracerebroventricular (ICV) methylene blue-injected rats which permitted visualization of the stereotaxic implantation of the injection cannulae and the injection site into the brain lateral ventricles. Cannula implantation reached the lateral ventricle as shown by the blue color and cannula scare (blood trace) (as referred to in Paxinos and Watson’s stereotaxic atlas). Moreover, methylene blue diffused to the hippocampus. B) Blood–brain barrier (BBB) permeability after endothelin-1 (ET-1) injection was assessed using albumin immunohistochemical (IHC) in IV Evans blue injected rats. ET-1 was administered intracerebroventricularly. Twenty-two hours later a solution of 3% Evans Blue dissolved in 0.9% saline was administered intravenously (4 ml/kg). No albumin labeling or blue trace was detected in the cortex or in the hippocampus of adult or juvenile rat brains, suggesting a lack of BBB breakdown after icv injection of ET-1. C) BBB permeability after ET-1 injection was also assessed by measuring (using real-time PCR) mRNA relative expression of a tight-junction component, the ZO-1 gene, in brain microvessels isolated 24 h after ET-1 treatment. Results represent mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.
Figure 1 Representative immunohistochemical staining of albumin in the adult and juvenile brains (scale bars, 5 μm).A) Stereotaxic implantation of the cannulae was checked using intracerebroventricular (ICV) methylene blue-injected rats which permitted visualization of the stereotaxic implantation of the injection cannulae and the injection site into the brain lateral ventricles. Cannula implantation reached the lateral ventricle as shown by the blue color and cannula scare (blood trace) (as referred to in Paxinos and Watson’s stereotaxic atlas). Moreover, methylene blue diffused to the hippocampus. B) Blood–brain barrier (BBB) permeability after endothelin-1 (ET-1) injection was assessed using albumin immunohistochemical (IHC) in IV Evans blue injected rats. ET-1 was administered intracerebroventricularly. Twenty-two hours later a solution of 3% Evans Blue dissolved in 0.9% saline was administered intravenously (4 ml/kg). No albumin labeling or blue trace was detected in the cortex or in the hippocampus of adult or juvenile rat brains, suggesting a lack of BBB breakdown after icv injection of ET-1. C) BBB permeability after ET-1 injection was also assessed by measuring (using real-time PCR) mRNA relative expression of a tight-junction component, the ZO-1 gene, in brain microvessels isolated 24 h after ET-1 treatment. Results represent mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.CC BY · PubMed Central
Figure 2 Expression of P-glycoprotein in freshly isolated rat brain microvessels after endothelin-1 treatment of juvenile and adult rats. Rats equivalent to pediatric (P21) and adult (P84) human brain were used. Twenty-four hours after intracerebroventricular (icv) injection of endothelin-1 (ET-1) was used to trigger inflammatory reactions, brain microvessels were isolated, and P-glycoprotein expression was assessed by western blot as reported in Methods. Results show no difference in P-glycoprotein expression after ET-1 treatment. Immunoblot represents mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.
Figure 2 Expression of P-glycoprotein in freshly isolated rat brain microvessels after endothelin-1 treatment of juvenile and adult rats. Rats equivalent to pediatric (P21) and adult (P84) human brain were used. Twenty-four hours after intracerebroventricular (icv) injection of endothelin-1 (ET-1) was used to trigger inflammatory reactions, brain microvessels were isolated, and P-glycoprotein expression was assessed by western blot as reported in Methods. Results show no difference in P-glycoprotein expression after ET-1 treatment. Immunoblot represents mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.CC BY · PubMed Central
Figure 3 Expression of breast cancer resistance protein (BCRP) in freshly isolated rat brain microvessels after endothelin-1 treatment of juvenile and adult rats. Rats equivalent to pediatric (P21) and adult (P84) human brain were used. Twenty-four hours after intracerebroventricular (icv) injection of endothelin-1 (ET-1) was used to trigger inflammatory reactions, brain microvessels were isolated, and BCRP expression was assessed by western blot as reported in Methods. Results show no difference in BCRP expression after ET-1 treatment. Immunoblot represents mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.
Figure 3 Expression of breast cancer resistance protein (BCRP) in freshly isolated rat brain microvessels after endothelin-1 treatment of juvenile and adult rats. Rats equivalent to pediatric (P21) and adult (P84) human brain were used. Twenty-four hours after intracerebroventricular (icv) injection of endothelin-1 (ET-1) was used to trigger inflammatory reactions, brain microvessels were isolated, and BCRP expression was assessed by western blot as reported in Methods. Results show no difference in BCRP expression after ET-1 treatment. Immunoblot represents mean ± S.E.M from three batches of brain endothelial microvessels. Statistical comparisons: *P <0.05, **P <0.01 and ***P <0.0001.CC BY · PubMed Central
Figure 4 P-glycoprotein activity regulation at the blood–brain barrier through activation of endothelin-1 signaling. Twenty-hours after endothelin-1 (ET-1) intracerebroventricular (icv) treatment, digoxin, a P-glycoprotein (P-gp) substrate, was administered intravenously in adult brain (A) and juvenile brain (B) during four hours (steady state (ss) achievement) at a concentration of 1 mg/kg/h. At the end of the infusion period, blood was sampled, brain was isolated and the administered substrate was quantified using mass spectrometry. P-gp transport activity was estimated by the ratio between the substrates’ unbound brain concentrations and unbound plasma concentrations. Unbound plasma digoxin concentration in adult (C) and juvenile rat (D) was also calculated. ET-1 induces an enhanced transporter activity of P-gp at the adult blood–brain barrier (BBB), whereas no significant change occurred in P-gp activity at the juvenile BBB. Data represent the mean concentration for five rat brains/plasma. Variability is given by bars ± S.E.M. Data were analyzed using Student’s t-test. Statistical comparisons: *P <0.05.
Figure 4 P-glycoprotein activity regulation at the blood–brain barrier through activation of endothelin-1 signaling. Twenty-hours after endothelin-1 (ET-1) intracerebroventricular (icv) treatment, digoxin, a P-glycoprotein (P-gp) substrate, was administered intravenously in adult brain (A) and juvenile brain (B) during four hours (steady state (ss) achievement) at a concentration of 1 mg/kg/h. At the end of the infusion period, blood was sampled, brain was isolated and the administered substrate was quantified using mass spectrometry. P-gp transport activity was estimated by the ratio between the substrates’ unbound brain concentrations and unbound plasma concentrations. Unbound plasma digoxin concentration in adult (C) and juvenile rat (D) was also calculated. ET-1 induces an enhanced transporter activity of P-gp at the adult blood–brain barrier (BBB), whereas no significant change occurred in P-gp activity at the juvenile BBB. Data represent the mean concentration for five rat brains/plasma. Variability is given by bars ± S.E.M. Data were analyzed using Student’s t-test. Statistical comparisons: *P <0.05.CC BY · PubMed Central
Figure 5 BCRP activity regulation at the blood–brain barrier through activation of endothelin-1 signaling. Twenty-hours after endothelin-1 (ET-1) intracerebroventricular (icv) treatment, prazosin, a BCRP substrate, was administered intravenously in adult brain (A) and juvenile brain (B) during four hours (steady state (ss) achievement) at a concentration of 1 mg/kg/h. At the end of the infusion period, blood was sampled, brain was isolated and the administered substrate was quantified using mass spectrometry. BCRP transport activity was estimated by the ratio between unbound prazosin brain concentrations and unbound plasma prazosin concentrations. Unbound plasma prazosin concentration in adult (C) and juvenile rat (D). Data represent the mean concentration for three or five rat brains/plasma. Variability is given by bars ± S.E.M. Data were analyzed using Student’s t-test. Statistical comparisons: *P <0.05.
Figure 5 BCRP activity regulation at the blood–brain barrier through activation of endothelin-1 signaling. Twenty-hours after endothelin-1 (ET-1) intracerebroventricular (icv) treatment, prazosin, a BCRP substrate, was administered intravenously in adult brain (A) and juvenile brain (B) during four hours (steady state (ss) achievement) at a concentration of 1 mg/kg/h. At the end of the infusion period, blood was sampled, brain was isolated and the administered substrate was quantified using mass spectrometry. BCRP transport activity was estimated by the ratio between unbound prazosin brain concentrations and unbound plasma prazosin concentrations. Unbound plasma prazosin concentration in adult (C) and juvenile rat (D). Data represent the mean concentration for three or five rat brains/plasma. Variability is given by bars ± S.E.M. Data were analyzed using Student’s t-test. Statistical comparisons: *P <0.05.CC BY · PubMed Central
Figure 6 Effect of endothelin-1 on glial activation in adult and juvenile brains. Representative immunohistochemical staining of glial fibrillary acidic protein (GFAP) in the juvenile (A) and adult (C) brains cortex and quantitative analysis of GFAP expression (E). Comparisons between groups were performed using one-way analysis of variance (ANOVA) with Bonferroni post test. Data are presented as mean ± S.E.M. Statistical significance was set at P <0.05. Each bar is expressed as the mean ± S.E.M; ***P <0 .0001 compared with control group. (D) Representative immunohistochemical staining of GFAP in the juvenile brain and adult (F) hippocampus and quantitative analysis of GFAP expression (E). Each bar is expressed as the mean ± S.E.M; ***P <0.0001 compared with control group.
Figure 6 Effect of endothelin-1 on glial activation in adult and juvenile brains. Representative immunohistochemical staining of glial fibrillary acidic protein (GFAP) in the juvenile (A) and adult (C) brains cortex and quantitative analysis of GFAP expression (E). Comparisons between groups were performed using one-way analysis of variance (ANOVA) with Bonferroni post test. Data are presented as mean ± S.E.M. Statistical significance was set at P <0.05. Each bar is expressed as the mean ± S.E.M; ***P <0 .0001 compared with control group. (D) Representative immunohistochemical staining of GFAP in the juvenile brain and adult (F) hippocampus and quantitative analysis of GFAP expression (E). Each bar is expressed as the mean ± S.E.M; ***P <0.0001 compared with control group.CC BY · PubMed Central
Figure 7 Cytokines and chemokines levels for 24 hours in juveniles (P21) and adult (P84) rat brains after a single intracerebral injection of endothelin-1. All cytokines, IL-1α, IL-1β, IL-6, IL-10, MCP-1/ccl2, fractalkine and TIMP-1 were simultaneously measured in brain and serum samples using the Agilent technology cytokine microarray (Tebu-bio). All brain values were corrected for individual serum measurements as described previously [6]. Comparisons between groups were performed using one-way analysis of variance (ANOVA) with the Student-Bonferroni post test. Data are presented as mean ± S.E.M. Statistical significance was set at P <0.05. Graph plotted as mean ± S.E.M. *P <0.05, **P <0.01, ***P < 0.0001 compared with animal controls. The number of animal tested: n = 3 or 5 rats for each group.
Figure 7 Cytokines and chemokines levels for 24 hours in juveniles (P21) and adult (P84) rat brains after a single intracerebral injection of endothelin-1. All cytokines, IL-1α, IL-1β, IL-6, IL-10, MCP-1/ccl2, fractalkine and TIMP-1 were simultaneously measured in brain and serum samples using the Agilent technology cytokine microarray (Tebu-bio). All brain values were corrected for individual serum measurements as described previously [6]. Comparisons between groups were performed using one-way analysis of variance (ANOVA) with the Student-Bonferroni post test. Data are presented as mean ± S.E.M. Statistical significance was set at P <0.05. Graph plotted as mean ± S.E.M. *P <0.05, **P <0.01, ***P < 0.0001 compared with animal controls. The number of animal tested: n = 3 or 5 rats for each group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 45

Metadata

Authors
Harati, R., Villégier, A.-S., Banks, W. A., & Mabondzo, A.
Affiliations
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • Institut national de l'environnement industriel et des risques (FR)
  • University of Washington (US)
Venue
Journal of Neuroinflammation
Published
2012-12
Volume
9
Issue
1
Pages
273-273
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2124502931
Cited by
45
References
64
Citations by year
2026: 2 · 2025: 9 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 2
FWCI
1.42
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Styrelsen för Internationellt Utvecklingssamarbete
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
blood-brain barrier, endothelin-1, P-glycoprotein, ABCG2, efflux pumps, neuroinflammation, brain maturation, juvenile brain, adult brain, cytokines and chemokines, glial activation, brain capillary endothelium, drug efflux, neuroprotection, postnatal development, rats, interleukin-1
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 2, Age Factors, Analysis of Variance, Animals, Animals, Newborn, Biological Transport, Biological Transport, Active, Blood-Brain Barrier, Brain, Drug Administration Routes, Glial Fibrillary Acidic Protein, Male, Methylene Blue, RNA, Messenger, Cytokines, Rats, Wistar, ATP Binding Cassette Transporter, Subfamily B, Gene Expression Regulation, Developmental, ATP-Binding Cassette Transporters, Endothelin-1, Rats, Microvessels, Zonula Occludens-1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. https://app.cochat.ai/papers/10.1186/1742-2094-9-273
The paper
Harati, R., Villégier, A.-S., Banks, W. A., & Mabondzo, A. (2012). Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-9-273

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.